Revision history of "Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group" (Q46619788)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 April 2024

  • curprev 19:2819:28, 7 April 2024KrBot talk contribs 63,502 bytes −1 Set a claim value: title (P1476): Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group undo
  • curprev 19:2819:28, 7 April 2024KrBot talk contribs 63,503 bytes −1 Changed Dutch label: Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group undo (restore)
  • curprev 19:2819:28, 7 April 2024KrBot talk contribs 63,504 bytes −1 Changed English label: Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group undo (restore)

30 December 2023

25 May 2022

15 February 2022

1 August 2021

18 August 2019

12 May 2019

22 December 2018

25 October 2018

24 December 2017

23 December 2017